Ledyard National Bank decreased its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,311 shares of the healthcare conglomerate’s stock after selling 484 shares during the quarter. Ledyard National Bank’s holdings in UnitedHealth Group were worth $7,708,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the company. Moneta Group Investment Advisors LLC raised its stake in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after acquiring an additional 11,812,017 shares in the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $5,210,004,000. Arrowstreet Capital Limited Partnership increased its position in UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after buying an additional 2,540,538 shares during the period. Morgan Stanley boosted its holdings in shares of UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock valued at $8,289,386,000 after acquiring an additional 1,893,192 shares during the period. Finally, Amundi boosted its stake in UnitedHealth Group by 29.0% during the 4th quarter. Amundi now owns 3,380,243 shares of the healthcare conglomerate’s stock worth $1,667,862,000 after purchasing an additional 759,440 shares during the period. 92.61% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Performance
NYSE:UNH opened at $461.58 on Monday. The firm has a 50-day moving average price of $481.95 and a two-hundred day moving average price of $487.87. The company has a market capitalization of $429.74 billion, a P/E ratio of 21.11, a price-to-earnings-growth ratio of 1.35 and a beta of 0.66. UnitedHealth Group Incorporated has a twelve month low of $445.68 and a twelve month high of $558.10. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.71.
UnitedHealth Group Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were paid a dividend of $1.88 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.65. The ex-dividend date of this dividend was Thursday, June 15th. This represents a $7.52 annualized dividend and a dividend yield of 1.63%. UnitedHealth Group’s dividend payout ratio is presently 34.39%.
Insider Transactions at UnitedHealth Group
In related news, CEO Andrew Witty sold 6,160 shares of the company’s stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the transaction, the chief executive officer now owns 86,564 shares of the company’s stock, valued at $42,199,084.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Andrew Witty sold 6,160 shares of the stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total transaction of $3,002,938.40. Following the completion of the sale, the chief executive officer now owns 86,564 shares of the company’s stock, valued at approximately $42,199,084.36. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,008 shares of the business’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the sale, the executive vice president now owns 10,359 shares of the company’s stock, valued at $5,019,764.22. The disclosure for this sale can be found here. Insiders have sold 8,852 shares of company stock worth $4,313,962 over the last quarter. 0.35% of the stock is currently owned by insiders.
Analysts Set New Price Targets
UNH has been the subject of several recent research reports. Oppenheimer reiterated an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research note on Monday, April 17th. JPMorgan Chase & Co. lowered their target price on UnitedHealth Group from $562.00 to $527.00 in a research note on Friday. Royal Bank of Canada reiterated an “outperform” rating and issued a $592.00 price objective on shares of UnitedHealth Group in a research report on Monday, April 17th. Truist Financial reduced their target price on shares of UnitedHealth Group from $610.00 to $580.00 in a research note on Wednesday, June 14th. Finally, Loop Capital increased their price target on shares of UnitedHealth Group from $590.00 to $600.00 and gave the stock a “buy” rating in a report on Monday, April 17th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $590.84.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- EV Mixed Signals: Sales Are Rising, But Inventory Slower To Move
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
- Cracks In The Labor Market? Not Yet, But They’re Coming
- Levi’s: Buy On The Dip Or Downtrend In Play?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
